Eiger BioPharmaceuticals, Inc. Quarterly Interest Expense in USD from Q1 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Interest Expense for the quarter ending December 31, 2023 was $1.43M, a 16.9% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. Interest Expense for the twelve months ending December 31, 2023 was $5.47M, a 32.3% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2023 was $5.47M, a 32.3% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2022 was $4.13M, a 16.1% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2021 was $3.56M, a 0.97% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $5.47M $1.43M +$206K +16.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-08
Q3 2023 $5.26M $1.41M +$320K +29.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.94M $1.34M +$409K +43.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.53M $1.29M +$399K +45% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.13M $1.22M +$320K +35.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 $3.81M $1.09M +$198K +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.61M $934K +$54K +6.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.56M $886K +$1K +0.11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.56M $900K -$13K -1.42% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $3.57M $894K -$12K -1.33% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.58M $880K -$11K -1.24% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.6M $885K +$1K +0.11% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $3.59M $913K +$25K +2.82% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 $3.57M $906K +$22K +2.49% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $3.55M $891K +$22K +2.53% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $3.53M $884K +$119K +15.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $3.41M $888K +$133K +17.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $3.27M $884K +$203K +29.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.07M $869K +$374K +75.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $2.7M $765K +$367K +92.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.33M $755K +$360K +91.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 $1.97M $681K +$293K +75.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.68M $495K +$117K +31% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.56M $398K +$35K +9.64% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.52M $395K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q3 2017 $388K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $378K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $363K -$322K -47% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q1 2016 $525K $685K +$175K +34.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $350K -$1.95M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $1.35M +$1.08M +397% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $445K Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $510K +$451K +764% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q3 2014 $271K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q1 2014 $59K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.